Suma Krishnan - Mar 11, 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Signature
/s/ Suma M. Krishnan
Stock symbol
KRYS
Transactions as of
Mar 11, 2024
Transactions value $
-$8,547,719
Form type
4
Date filed
3/11/2024, 08:27 PM
Previous filing
Mar 1, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Sale -$447K -2.66K -0.17% $168.15 1.57M Mar 11, 2024 Direct F1, F2
transaction KRYS Common Stock Sale -$278K -1.65K -0.1% $168.96 1.57M Mar 11, 2024 Direct F1, F3
transaction KRYS Common Stock Sale -$1.37M -8.04K -0.51% $170.42 1.56M Mar 11, 2024 Direct F1, F4
transaction KRYS Common Stock Sale -$936K -5.47K -0.35% $171.09 1.56M Mar 11, 2024 Direct F1, F5
transaction KRYS Common Stock Sale -$482K -2.8K -0.18% $172.21 1.56M Mar 11, 2024 Direct F1, F6
transaction KRYS Common Stock Sale -$622K -3.59K -0.23% $173.30 1.55M Mar 11, 2024 Direct F1, F7
transaction KRYS Common Stock Sale -$139K -800 -0.05% $174.13 1.55M Mar 11, 2024 Direct F1, F8
transaction KRYS Common Stock Sale -$361K -2.15K -0.13% $167.99 1.64M Mar 11, 2024 By Spouse F9, F10, F11, F12
transaction KRYS Common Stock Sale -$381K -2.25K -0.14% $168.88 1.63M Mar 11, 2024 By Spouse F9, F10, F12, F13
transaction KRYS Common Stock Sale -$870K -5.11K -0.31% $170.32 1.63M Mar 11, 2024 By Spouse F9, F10, F12, F14
transaction KRYS Common Stock Sale -$1.37M -8K -0.49% $170.93 1.62M Mar 11, 2024 By Spouse F9, F10, F12, F15
transaction KRYS Common Stock Sale -$485K -2.82K -0.17% $172.06 1.62M Mar 11, 2024 By Spouse F9, F10, F12, F16
transaction KRYS Common Stock Sale -$581K -3.36K -0.21% $173.09 1.61M Mar 11, 2024 By Spouse F9, F10, F12, F17
transaction KRYS Common Stock Sale -$229K -1.31K -0.08% $174.00 1.61M Mar 11, 2024 By Spouse F9, F10, F12, F18
holding KRYS Common Stock 90K Mar 11, 2024 By SMK Trust
holding KRYS Common Stock 50K Mar 11, 2024 By Krishnan Family Trust F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 11, 2023, and will terminate on September 11, 2024, and contemplates sales of 25,000 shares per quarter with a limit price of $100.00 per share.
F2 The transaction was executed in multiple trades ranging from $167.5700 to $168.5600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The transaction was executed in multiple trades ranging from $168.5700 to $169.4900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 The transaction was executed in multiple trades ranging from $169.7600 to $170.7500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5 The transaction was executed in multiple trades ranging from $170.7600 to $171.7500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6 The transaction was executed in multiple trades ranging from $171.8300 to $172.8000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F7 The transaction was executed in multiple trades ranging from $172.9000 to $173.8800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F8 The transaction was executed in multiple trades ranging from $173.9000 to $174.5000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F9 These sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish S. Krishnan. The Rule 10b5-1 trading plan started on September 11, 2023, and will terminate on September 11, 2024, and contemplates sales of 25,000 shares per quarter with a limit price of $100.00 per share.
F10 These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish S. Krishnan.
F11 The transaction was executed in multiple trades ranging from $167.4900 to $168.4800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F12 Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.
F13 The transaction was executed in multiple trades ranging from $168.4900 to $169.3300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F14 The transaction was executed in multiple trades ranging from $169.5400 to $170.5300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F15 The transaction was executed in multiple trades ranging from $170.5400 to $171.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F16 The transaction was executed in multiple trades ranging from $171.5700 to $172.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F17 The transaction was executed in multiple trades ranging from $172.5800 to $173.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F18 The transaction was executed in multiple trades ranging from $173.6800 to $174.5000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F19 Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.